Hematology
Review: Estimated Prevalence of VTE 14.1 Percent in COVID-19
WEDNESDAY, Oct. 7, 2020 (HealthDay News) — The overall prevalence of venous thromboembolism (VTE) in patients with COVID-19 is estimated to be 14.1 percent, with a higher prevalence for patients in the intensive care unit (ICU), according to a review published online Sep. 25 in Research and Practice in Thrombosis and Haemostasis. Stephan Nopp, M.D.,...
Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
FRIDAY, Oct. 2, 2020 (HealthDay News) — There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online Sept. 16 in JAMA Network Open. Vasily Giannakeas, M.P.H., from University of Toronto, and colleagues used the Surveillance, Epidemiology and End Results...
Antibodies Decrease With Time After COVID-19 Symptom Onset
FRIDAY, Oct. 2, 2020 (HealthDay News) — Antibodies decrease with time after COVID-19 symptom onset, according to a research letter published online Oct. 1 in Blood. Josée Perreault, Ph.D., from Héma-Québec in Montréal, and colleagues analyzed severe acute respiratory syndrome coronavirus 2 spike protein receptor binding domain (RBD) antibody titers from potential COVID-19 convalescent plasma...
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
THURSDAY, Oct. 1, 2020 (HealthDay News) — For patients with non-small cell lung cancer (NSCLC) with programmed death ligand 1 (PD-L1) expression, treatment with atezolizumab results in longer overall survival than chemotherapy, according to a study published in the Oct. 1 issue of the New England Journal of Medicine. Roy S. Herbst, M.D., Ph.D., from...
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs. John D. Birkmeyer, M.D., from Sound Physicians in Tacoma, Washington, and colleagues conducted a...
Diagnoses of Common Conditions Declined in March to May 2020
FRIDAY, Sept. 25, 2020 (HealthDay News) — Diagnoses of common conditions decreased substantially between March and May 2020, according to a study published online Sept. 23 in The Lancet Public Health. The research was published to coincide with the European Society of Clinical Microbiology and Infectious Diseases Conference on Coronavirus Diseases, held virtually from Sept....
Black Women Receive Less Timely Breast Cancer Treatment
MONDAY, Sept. 21, 2020 (HealthDay News) — Black women experience longer waits for treatment initiation after a breast cancer diagnosis and prolonged duration of treatment versus White women, according to a study published online Sept. 21 in Cancer. Marc A. Emerson, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues evaluated disparities...
Lung Cancer Treatment Plans Changed Due to Pandemic
FRIDAY, Sept. 18, 2020 (HealthDay News) — More than half of patients have experienced changes in their lung cancer treatment plan as a result of the COVID-19 pandemic, according to a research letter published online Sept. 17 in JAMA Oncology. Arielle Elkrief, M.D., from the McGill University Health Center in Montreal, and colleagues examined changes...
Spironolactone Not Tied to Breast Cancer Recurrence
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Spironolactone is not independently associated with increased breast cancer recurrence, according to a study published in the October issue of the Journal of the American Academy of Dermatology. Chapman Wei, from the George Washington University in Washington, D.C., and colleagues used the Humana Insurance database to identify breast...
More Medical News
